P/E Ratio

The P/E ratio of 25.3x means that investors are currently paying $25.30 for every $1.00 of Agilent’s annual earnings per share – a standard measure of how expensive the stock is relative to its profitability.

This ratio sits below the Healthcare sector median of 28.3x, placing the stock at the 38th percentile among its peers, indicating a lower valuation than most companies in the industry. The metric has been completely stable over the last eight quarters, with no change year-over-year and no change quarter-over-quarter. The combination of a below-average P/E and a flat trend suggests a moderate valuation with no recent expansion or contraction, implying neither a clear discount nor a premium – a neutral risk profile. This stability and relative positioning directly support the overall NEUTRAL verdict on the stock, as the metric does not indicate undue overvaluation or undervaluation.

Frequently Asked Questions

Closest Sector Peers